Диссертация (1140935), страница 34
Текст из файла (страница 34)
DiBartola [et al.] // Fluid,Electrolyte, and Acid-base Disorders in Small Animal Practice, 4th edn. - St.Louis, MO. – Elsevier. - 2011. – P. 120–194.277.Schlüter, K.D. Stem cell mobilization versus stem cell homing: potentialrole for parathyroid hormone? / K.D. Schlüter, R. Schreckenberg, S. Wenzel //Cardiovasc. Res. – 2008. – Vol.
77. – P. 612–613.278.Scherer, A. Alteration of human blood cell transcriptome in uremia. / A.Scherer, O.P. Günther, R.F. Balshaw, Z. Hollander [et al.] // BMC Med.Genomics. – 2013. – Vol. 6. – P. 23.279.Sebastian, E.M. Differential effects of intermittent PTH(1-34) and PTH(7-34) on bone microarchitecture and aortic calcification in experimental renalfailure. / E.M.
Sebastian, L.J. Suva, P.A. Friedman // Bone. – 2008. – Vol. 43 (6).– P. 1022-1030.280.Seeliger, S. The parathyroid hormone-2 receptor is expressed on humanleukocytes and down-regulated in hyperparathyroidism. / S. Seeliger, M.Hausberg, I. Eue, T. Usdin, K.H. Rahn, M. Kosch // Clin. Nephrol. – 2003. – Vol.59 (6). – P. 429-435.281.Seiler, S. Clinical relevance of FGF-23 in chronic kidney disease.
/ S.Seiler, G.H. Heine, D. Fliser // Kidney Int. – 2009. – Vol. 76, Suppl 114. – P.S34–S42.282.Shurtz-Swirski, R. Parathyroid hormone and the cellular immune system. /204R. Shurtz-Swirski, T. Shkolnik, S.M. Shasha // Nephron. – 1995. – Vol. 70. – P.21-24.283.Silva, AC. Oxidative stress, superoxide production, and apoptosis ofneutrophils in dogs with chronic kidney disease. / AC. Silva, B.F. de Almeida,C.S. Soeiro, W.L.
Ferreira, V.M. de Lima, P.C. Ciarlini // Can. J. Vet. Res. –2013. – Vol. 77 (2). – P. 136-141.284.Silver, J. FGF23 and PTH–double agents at the heart of CKD. / J. Silver,M. Rodriguez, E. Slatopolsky // Nephrol. Dial. Transplant. – 2012. – Vol. 27, №5.
– P. 1715–1720.285.Simone, R. The frequency of regulatory CD3+CD8+CD28- CD25+ Tlymphocytes in human peripheral blood increases with age. / R. Simone, A.Zicca, D. Saverino // J. Leukoc. Biol. – 2008. – Vol. 84. – P. 1454–1461.286.Singh, A.T. G alpha12/G alpha13 subunits of heterotrimeric G proteinsmediate parathyroid hormone activation of phospholipase D in UMR-106osteoblastic cells / A.T.
Singh, A. Gilchrist, T. Voyno-Yasenetskaya, J.M.Radeff-Huang, P.A. Stern. // Endocrinology. – 2005. – Vol. 146. – P. 2171–2175.287.Slatopolsky, E. Pathogenesis of secondary hyperparathyroidism. / E.Slatopolsky, J.A. Delmez. // Miner. Electrolyte Metab. – 1995. – Vol. 21(1–3). –P. 91–96.288.Smith, J.C. Augmentation of central arterial pressure in mild primaryhyperparathyroidism.
/ J.C. Smith, M.D. Page, R. John, M.H. Wheeler, J.R.Cockcroft [et al.] // J. Clin. Endocrinol. Metab. – 2000. – Vol. 85. – P. 3515–3519.289.Smogorzewski, M. Defects in B-cell function and metabolism in uremia:role of parathyroid hormone. / M. Smogorzewski, S.G. Massry / Kidney Int.Suppl. – 2001.
– Vol. 78. – P. S186-189.290.Smogorzewski, M. Downregulation of PTH, PTHrP receptor in heart inCRF: Role of [Ca21]i. / M. Smogorzewski, J. Tian, S.G. Massry // Kidney Int. –1995. – Vol. 47. – P. 1182–1186.291.Smogorzewski, M.J. Liver metabolism in CRF. / M.J. Smogorzewski, S.G.205Massry // Am. J. Kidney Dis. – 2003. – Vol. 41 (3 Suppl 1). – P. S127-132.292.Soldati, L. Chloride fluxes activated by parathyroid hormone in humanerythrocytes. / L.
Soldati, D. Adamo, R. Spaventa, G. Bianchi, G. Vezzoli //Biochem. Biophys. Res. Commun. – 2000. – Vol. 269 (2). – P. 470-473.293.Sommer, S. The phosphatonins and the regulation of phosphate transportand vitamin D metabolism. / S. Sommer, T. Berndt, T. Craig [et al.] // J. Steroid.Biochem. Mol. Biol. – 2007. – Vol. 103б № 3–5.
– P. 497–503.294.Sourbier, C. Parathyroid hormone-related protein in human renal cellcarcinoma. / C. Sourbier, T. Massfelder // Cancer Lett. – 2006. – Vol. 240. – P.170–182.295.StatSoft : электронный учебник по статистике [Электронный ресурс]. –Москва, 2012. – Режим доступа:http://www.StatSoft.ru/home/textbook/default.htm.296.Stenvinkel, P. Are there two types of malnutrition in chronic renal failure?Evidenceforrelationshipsbetweenmalnutrition,inflammationandatherosclerosis (MIA syndrome) / P.
Stenvinkel, O. Heimbürger, B. Lindholm,G.A. Kaysen, J. Bergström. // Nephrology Dialysis Transplantation. – 2000. –Vol. 15 (7). – P. 953–960.297.Stewart, J.H. The pattern of excess cancer in dialysis and transplantation. /J.H. Stewart, C.M. Vajdic, M.T. van Leeuwen, J.
Amin, A.C. Webster, J.R.Chapman, S.P. McDonald, A.E. Grulich, M.R. McCredie. // Nephrol. Dial.Transplant. – 2009. – Vol. 24. – P. 3225–3231.298.Stinghen,A.E.Immunemechanismsinvolvedincardiovascularcomplications of chronic kidney disease / A.E. Stinghen, S. Bucharles, M.C.Riella [et al.] // Blood Purif. – 2010. – Vol. 29, № 2. – P. 114-120.299.Strewler, G.J. The parathyroid hormone-related protein. / G.J.
Strewler //Endocrinol. Metab. Clin. North. Am. – 2000. – Vol. 29 (3). – P. 629-645.300.Sung, C.C. Oxidative stress and nucleic acid oxidation in patients withchronic kidney disease. / C.C. Sung, Y.C. Hsu, C.C. Chen, Y.F. Lin, C.C. Wu. //Oxid. Med. Cell. Longev. – 2013. – Vol. 2013. - 301982. – doi:20610.1155/2013/301982.301.Sukumar, D. The high serum monocyte chemoattractant protein-1 inobesity is influenced by high parathyroid hormone and not adiposity. /D.
Sukumar, N.C. Partridge, X. Wang, S.A. Shapses. // J. Clin. Endocrinol.Metab. – 2011. – Vol. 96 (6). – P. 1852-1858.302.Szeto, F.L. Involvement of the vitamin D receptor in the regulation of NF-kappa b activity in fibroblasts. / F.L. Szeto, J. Sun, J. Kong [et al.] // J. Steroid.Biochem. Mol. Biol. – 2007. – Vol. 103, № 3–5. – P. 563–566.303.Tamasi, J.A. Monocyte chemoattractant protein-1 is a mediator of theanabolic action of parathyroid hormone on bone.
/ J.A. Tamasi, A. Vasilov, E.Shimizu, N. Benton, J. Johnson, C.L. Bitel, N. Morrison, N.C.Partridge // J.Bone. Miner. Res. – 2013. – Vol. 28 (9). – P. 1975-1986.304.Tassone, F. Insulin resistance is not coupled with defective insulinsecretion in primary hyperparathyroidism. / F. Tassone, M.
Procopio, L. Gianotti,G. Visconti, A. Pia [et al.] // Diabet Med. – 2009. – Vol. 26 – P. 968–973.305.Tawfeek, H. Disruption of PTH receptor 1 in T cells protects against PTH-induced bone loss. / H. Tawfeek, B. Bedi, J.Y. Li, J. Adams, T.
Kobayashi, M.N.Weitzmann, H.M. Kronenberg, R. Pacifici // PLoS One. - 2010. – Vol. 5 (8). e12290. doi: 10.1371/journal.pone.0012290.306.Tayebjee, M.H. Matrix metalloproteinase-9 and tissue inhibitor ofmetalloproteinase-1 in hypertension and their relationship to cardiovascular riskand treatment: a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial(ASCOT). / M.H. Tayebjee, S. Nadar, A.D. Blann, D. Gareth Beevers, R.J.MacFadyen [et al.] // Am. J. Hypertens. - 2004. – Vol. 17. – P.
764–769.307.Terauchi, M. T-lymphocytes amplify the anabolic activity of parathyroidhormone through Wnt10b signaling. / M. Terauchi, J.Y. Li, B. Bedi [et al.] //Cell. Metab. – 2009. – Vol. 10 (3). – P. 229–240.308.Trevisani, V.F. Teriparatide (recombinant human parathyroid hormone 1-34) in postmenopausal women with osteoporosis: systematic review. / V.F.Trevisani, R.
Riera, A.M. Imoto, H. Saconato, A.N. Atallah // San Paulo Med. J.207– 2008. - Vol. 126. – P. 279–284.309.Tuma, S.N. Augmented polymorphonuclear chemiluminescence in patientswith secondary hyperparathyroidism. / S.N. Tuma, R.R. Martin, L.E. Mallette, G.Eknoyan // Journal of Laboratory and Clinical Medicine. – 1981.
– Vol. 97 (2). –P. 291–298.310.Tzanno-Martins, C. Immune response in hemodialysis patients: is there anydifference when low and high iPTH levels are compared? / C. Tzanno-Martins, E.Futata, V. Jorgetti , A.J. Duarte // Clin. Nephrol. – 2000. – Vol. 54 (1). – P. 2229.311.Tzanno-Martins, C. Restoration of impaired T-cell proliferation afterparathyroidectomy in hemodialysis patients. / C. Tzanno-Martins, E. Futata, V.Jorgetti, A.J. Duarte. // Nephron. – 2000.
– Vol. 84 (3). – P. 224-227.312.Usdin, T.B. Evidence for a parathyroid hormone-2 receptor selective ligandin the hypothalamus. / T.B. Usdin // Endocrinology. - 1997. – Vol. 138. – P. 831–834.313.Usdin, T.B. Identification and functional expression of a receptorselectively recognizing parathyroid hormone, the PTH2 receptor. / T.B. Usdin, C.Gruber, T.I.
Bonner // J. Biol. Chem. - 1995. – Vol. 270. P. 15455–15458.314.Usdin, T.B. The PTH2 receptor and TIP39: a new peptide-receptorsystem. / T.B. Usdin // Trends Pharmacol. Sci. – 2000. – Vol. 21. – P. 128–130.315.Usdin, T.B. TIP39: a new neuropeptide and PTH2 receptor agonist fromhypothalamus. / T.B. Usdin, S.R.J. Hoare, T. Wang, É. Mezey, J.A. Kowalak //Nature Neuroscience.
– 1999. – Vol. 2. – P. 941–943.316.Vadher, S. Translationalregulationofparathyroidhormonegeneexpression and RNA: Protein interactions. / S. Vadher, N.S. Hawa, J.L.O'Riordan, S.M. Farrow // J. Bone Miner. Res. - 1996. – Vol. 11. – P. 746–753.317.van Ballegooijen, A.J. Serum parathyroid hormone in relation to all-cause andcardiovascular mortality: the Hoorn study / A.J. van Ballegooijen, I. Reinders, M. Visser etal. // Journal of Clinical Endocrinology & Metabolism. – 2013. – Vol.
98. – Р. E638-E645.318.Vanholder, R. An update on protein-bound uremic retention solutes / R.208Vanholder, E. Schepers, A. Pletinck [et al.] // J. Ren. Nutr. – 2012. – Vol. 22. – Р.90-94.319.van Riemsdijk, I.C. T cells activate the tumor necrosis factor-alpha systemduring hemodialysis, resulting in tachyphylaxis. / I.C. van Riemsdijk, C.C. Baan,E.H. Loonen, C.J.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
